Tirzepatide is a dual GIP and GLP-1 receptor agonist peptide developed for advanced research applications involving metabolic regulation, insulin signaling, and incretin pathway studies.
Tirzepatide is a synthetic multi-receptor agonist peptide engineered to simultaneously target glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual-mechanism design makes it an important compound in metabolic and endocrine research focused on insulin sensitivity, glucose metabolism, and energy balance pathways.
Due to its unique receptor activity profile, Tirzepatide is frequently studied in controlled laboratory environments for its effects on incretin biology, pancreatic signaling, nutrient metabolism, and hormonal regulation. Its extended activity profile allows researchers to examine prolonged receptor interaction and downstream metabolic responses.
Produced under strict quality control and purification protocols, Tirzepatide is supplied as a high-purity lyophilized peptide intended for scientific and analytical research applications requiring consistency and stability.
Key Research Characteristics
• Dual GIP and GLP-1 receptor agonist
• High purity research peptide
• Designed for metabolic pathway research
• Stable lyophilized formulation
• Suitable for endocrine and glucose metabolism studies
• Research-grade manufacturing standards
Important Notice
This product is intended strictly for research and laboratory use only. Not for human consumption, medical use, or therapeutic applications. This material should only be handled by qualified professionals in properly equipped research facilities.
High-quality research-grade peptides and compounds engineered for scientific innovation and laboratory use.